UCB Ventures News and Activities

UCB Ventures is owned by UCB.

UCB is one of the...

• Forbes Global 2000 (#1031);
• Stoxx 600;
• TOB Iconic 10,000.

UCB is a company listed under the stock ticker UCB (BE).

UCB has a direct presence in 9 countries.

UCB has 9 subsidiaries including UCB Australia, UCB Canada and UCB France.

They are in:

• Pharmaceuticals90%
• Fund10%

Acquisition, funding and merger involving UCB.

• UCB has announced the acquisition of Candid Therapeutics  (posted on May 5 2026).
• UCB has announced the acquisition of Neurona Therapeutics  (posted on April 20 2026).

View the org chart displaying its 3 main executives

Most searched biographies at UCB Ventures

• Erica Whittaker, Managing Partner
• Alicia Irurzun-Lafitte, Partner
• Steven Biesmans, Principal

Create your alert
to follow the executive moves at UCB Ventures.

UCB has 1,650 competitors including BlackRock (United States (USA)), KKR (United States (USA)) and Griffin Gaming Partners (United States (USA)).

Popular M&A news in Fund

• Arcline has announced the acquisition of AstroNova  (posted on June 24 2026).
• The project of Yellow Wood Partners acquiring Edgewell Personal Care has been abandoned  (posted on June 24 2026).
• EQT has announced the acquisition of Exolaunch  (posted on June 22 2026).

Popular contacts in Fund

• Antonio Gracias - Founder, Chief Executive Officer and Chief Investment Officer at Valor Equity Partners
• Salim Ramji - Chief Executive Officer and Director at Vanguard
• Hemant Taneja - Chief Executive Officer and Managing Director at General Catalyst Partners

Learn more about the Fund industry

Press releases by UCB Ventures

Social media about UCB Ventures

• UCB Ventures on Wikipedia, Google News & Yahoo Finance
• UCB Ventures on LinkedIn, X (Twitter) & YouTube